These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9323118)

  • 1. Coupling of hemodynamic measurements with oxygen during exercise does not improve risk stratification in patients with heart failure.
    Wilson JR; Chomsky D
    Circulation; 1997 Sep; 96(6):2095-7. PubMed ID: 9323118
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe heart failure in the setting of relatively mild mitral stenosis: the role of invasive hemodynamic assessment.
    Sorajja P; Borlaug BA
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):739-48. PubMed ID: 18949802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
    de Groote P; Dagorn J; Soudan B; Lamblin N; McFadden E; Bauters C
    J Am Coll Cardiol; 2004 May; 43(9):1584-9. PubMed ID: 15120815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methodology of exercise test in patients with heart failure. Maximal test and submaximal test].
    Faggiano P; Gualeni A
    Ital Heart J Suppl; 2000 Mar; 1(3):313-9. PubMed ID: 10815256
    [No Abstract]   [Full Text] [Related]  

  • 5. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
    de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
    Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?
    Opasich C; Pinna GD; Mazza A; Febo O; Riccardi R; Riccardi PG; Capomolla S; Forni G; Cobelli F; Tavazzi L
    Eur Heart J; 2001 Mar; 22(6):488-96. PubMed ID: 11237544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of exercise testing and gas-exchange measurement in the prognostic assessment of patients with heart failure.
    Myers J; Gullestad L
    Curr Opin Cardiol; 1998 May; 13(3):145-55. PubMed ID: 9649936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does oxygen saturation or distance walked predict rehospitalization in heart failure?
    Howie-Esquivel J; Dracup K
    J Cardiovasc Nurs; 2008; 23(4):349-56. PubMed ID: 18596499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.
    Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methodology of exercise test in patients with heart failure. Serial tests: rationale and interpretation of results].
    Corrà U; Bosimini E
    Ital Heart J Suppl; 2000 Mar; 1(3):326-31. PubMed ID: 10815258
    [No Abstract]   [Full Text] [Related]  

  • 11. The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies.
    Stempfle HU; Alt A; Stief J; Siebert U
    J Heart Lung Transplant; 2008 Feb; 27(2):222-8. PubMed ID: 18267231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the uniformity of cardiopulmonary exercise testing in chronic heart failure.
    Myers J
    Am Heart J; 2001 Sep; 142(3):384-7. PubMed ID: 11526348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Exercise testing in heart failure; utility and limitations].
    Straburzyńska-Migaj E; Szyszka A; Cieśliński A
    Kardiol Pol; 2003 Jan; 58(1):77-9. PubMed ID: 14502312
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognosis in heart failure: the value of parameter-changes over time.
    Préda I; Nyolczas N
    Eur Heart J; 2000 Jan; 21(2):98-9. PubMed ID: 10637081
    [No Abstract]   [Full Text] [Related]  

  • 15. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure.
    Cohen-Solal A; Tabet JY; Logeart D; Bourgoin P; Tokmakova M; Dahan M
    Eur Heart J; 2002 May; 23(10):806-14. PubMed ID: 12009721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure.
    Ingle L; Goode K; Carroll S; Sloan R; Boyes C; Cleland JG; Clark AL
    Int J Cardiol; 2007 Jun; 118(3):350-5. PubMed ID: 17067694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmia risk stratification based on clinical and functional data].
    Rostagno C; Lazzeri C; Gensini GF
    Ital Heart J Suppl; 2001 Dec; 2(12):1270-7. PubMed ID: 11838347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impedance cardiography for the assessment of hemodynamic response during cardiopulmonary exercise test in patient with heart failure - a case report].
    Siebert J; Zielińska D; Trzeciak BG; Bakuła S
    Kardiol Pol; 2010 Mar; 68(3):311-3. PubMed ID: 20411455
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
    Scardovi AB; De Maria R; Coletta C; Aspromonte N; Perna S; Cacciatore G; Parolini M; Ricci R; Ceci V
    J Card Fail; 2007 Aug; 13(6):445-51. PubMed ID: 17675058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.
    Lund LH; Aaronson KD; Mancini DM
    Am J Cardiol; 2005 Mar; 95(6):734-41. PubMed ID: 15757599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.